Cell Movement Through a TH2-Conditioned Extracellular Matrix
细胞通过 TH2 调节的细胞外基质运动
基本信息
- 批准号:8646955
- 负责人:
- 金额:$ 39.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-01 至
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAcuteAdhesionsAdhesivesAffectAlternative SplicingAntibodiesAreaAsthmaBehaviorBenignBinding SitesBiologicalBiologyBiopsyBlocking AntibodiesBlood PlateletsBronchoalveolar LavageCell Surface ReceptorsCellsCharacteristicsChronicConnective TissueDataDepositionDevelopmentEmployee StrikesEndothelial CellsEnvironmentEotaxinEpithelial CellsExtracellular MatrixExtracellular Matrix ProteinsExtrinsic asthmaFibroblastsGlutamic AcidGoalsGranulocyte-Macrophage Colony-Stimulating FactorHomologous GeneHumanITGAM geneITGB2 geneIn VitroInflammationInflammatoryInstructionIntegrinsInterleukin-3Interleukin-5KnowledgeLearningLeftLeukocytesLigandsLungLung diseasesMapsMediatingMediator of activation proteinModelingMovementMusOutcomePatientsPrincipal InvestigatorProcessProteinsReagentRegulationResearchRoleSamplingSiteSpecificityStaining methodStainsStructure-Activity RelationshipTGFBI geneTh2 CellsThe SunTransforming Growth Factor-Beta Induced Protein IGH3Vascular Cell Adhesion Molecule-1Vitamin Kairway inflammationairway remodelingantigen challengeasthmatic airwaybasecarboxylatecarboxylationcell motilitycytokinedensityeosinophileosinophilic inflammationinsightmigrationnovelperiostinreceptorresearch studyresponsesurface coatingtraffickingtumor
项目摘要
Our long-term goal is to understand how eosinophils (EOS) traffic to and interact in the ainway and contribute
to the progression of asthma. aM32 integrin (CD11b/CD18) is highly activated on EOS obtained by
bronchoalveolar lavage after segmental antigen challenge, suggesting that aM(32 functions becomes
important as EOS extravasate to and migrate in the lung. However, little is known about roles of aMp2 and
relevant ligand(s) in adhesion, migration, and activities of EOS in the airway. The overall objective of this
proposal is to determine the role of aMp2 in modulating behavior of EOS in the ainway. Based on our
preliminary data and current understanding of EOS biology and the extracellular matrix (ECM) in asthma, the
current hypothesis is that periostin, an ECM protein characteristic of inflammation driven by T helper type 2
cells and found in the asthmatic ain/vay, is a dominant adhesive ligand for EOS aMp2 integrin and that the
aMp2-periostin interaction is an important determinant of EOS function. Aim 1 is to define roles of aMp2,
periostin and TGF-P-induced protein (TGFBI), a periostin homolog also found in lung, in adhesion, migration,
sun/ival, and other functions of EOS activated by IL-3, IL-5, GM-CSF, or other activators. Aim 2 is to
determine the structure-function relationship ofthe recognition of periostin by aMP2, map the aMp2-binding
site(s), and define minimal constructs that when immobilized support, and when soluble block, EOS
adhesion and migration. How the vitamin K-dependent y-carboxylation and alternative splicing affect
periostin's biological activities will also be determined. Aim 3 is to understand the mechanism and
significance ofthe striking increase of periostin that is found in the asthmatic airway. Periostin secretion from
fibroblasts and epithelial cells stimulated by TGF-p or other factors, as well as its deposition into ECM and
turnover will be analyzed. Antibodies to the various forms of periostin and TGFBI will be developed for
localization in bronchial biopsies after segmental antigen challenge. Achieving the goals of this proposal will
provide novel knowledge and a better understanding of EOS trafficking and functions and the interplay
between EOS and the ECM in Th2-driven inflammation, and will generate agents and reagents that will allow
this interplay to be studied and modulated.
RELE^VANCE (See instructions):
The proposed research will determine how the connective tissue protein periostin, which is strongly up-
regulated in asthma, interacts with its cell-surface receptor protein aMP2 integrin (CD11b/CD18) on activated
EOS, and supports attachment and migration of EOS. The project will provide new insights into the
movement of EOS in the asthmatic ainway and the biology of connective tissue in the diseased lung.
我们的长期目标是了解嗜酸性粒细胞(EOS)如何在气道中流动并相互作用并做出贡献
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NIZAR N JARJOUR其他文献
NIZAR N JARJOUR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NIZAR N JARJOUR', 18)}}的其他基金
Investigating the mechanisms by which systemic inflammation promotes Alzheimer’s disease: Asthma as a model and modifiable risk factor
研究全身炎症促进阿尔茨海默病的机制:哮喘作为模型和可改变的危险因素
- 批准号:
10661382 - 财政年份:2023
- 资助金额:
$ 39.37万 - 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
- 批准号:
8175591 - 财政年份:2011
- 资助金额:
$ 39.37万 - 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
- 批准号:
8849951 - 财政年份:2011
- 资助金额:
$ 39.37万 - 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
- 批准号:
8496108 - 财政年份:2011
- 资助金额:
$ 39.37万 - 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
- 批准号:
8680346 - 财政年份:2011
- 资助金额:
$ 39.37万 - 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
- 批准号:
8315751 - 财政年份:2011
- 资助金额:
$ 39.37万 - 项目类别:
Role of Eosinophils in T-Cells Function and Remodeling
嗜酸性粒细胞在 T 细胞功能和重塑中的作用
- 批准号:
7843278 - 财政年份:2009
- 资助金额:
$ 39.37万 - 项目类别:
Role of Eosinophils in Airway Inflammation and Remodeling
嗜酸性粒细胞在气道炎症和重塑中的作用
- 批准号:
7824378 - 财政年份:2009
- 资助金额:
$ 39.37万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 39.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 39.37万 - 项目类别:
Operating Grants